Larry C Heaton II bought $30k of ZOMDF
CEO at Zomedica Corp.. 500,000 shares at an average of $0.06, traded Mar 17, 2025, filed Mar 18, 2025.
Score components
- +25RoleCEO
- +5Trade size$30k at market
- +10Relative to holdingsHoldings up 100%
- 0Price contextNo price history yet
- +15Cluster4 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -26.9%, 3m -35.8%, 6m +9.0%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001654954-25-002960, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 17, 2025 | POpen-market purchase Common Stock, without par value | +10,000 | $0.05 | $540 | 510,000 | Mar 18, 2025 |
| Mar 17, 2025 | POpen-market purchase Common Stock, without par value | +118,855 | $0.06 | $6,894 | 628,855 | Mar 18, 2025 |
| Mar 17, 2025 | POpen-market purchase Common Stock, without par value | +191,817 | $0.06 | $12k | 820,672 | Mar 18, 2025 |
| Mar 17, 2025 | POpen-market purchase Common Stock, without par value | +179,328 | $0.06 | $11k | 1,000,000 | Mar 18, 2025 |
Related signals
Other insiders at Zomedica Corp. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 56Moderate | Zomedica Corp. | Russell Kevin Klass Sr. Vice President, Sales | $11k 104,000 shares | - | |
| 36Weak | Zomedica Corp. | Russell Kevin Klass Vice President of Sales | $23k 216,899 shares | +4% | |
| 43Moderate | Zomedica Corp. | Johnny D Powers director | $21k 200,000 shares | +5% | |
| 51Moderate | Zomedica Corp. | Johnny D Powers director | $32k 300,000 shares | +8% | |
| 44Moderate | Zomedica Corp. | Johnny D Powers director | $56k 500,000 shares | +15% | |
| 55Moderate | Zomedica Corp. | Larry C Heaton II CEO | $28k 250,000 shares | +25% | |
| 28Weak | ZOMDFbuy Zomedica Corp. | Russell Kevin Klass Sr Vice President, Sales | $15k 150,000 shares | +3% | |
| 28Weak | ZOMDFbuy Zomedica Corp. | Russell Kevin Klass Sr Vice President, Sales | $12k 120,000 shares | +2% | |
| 23Weak | ZOMDFbuy Zomedica Corp. | Russell Kevin Klass Sr Vice President, Sales | $475 5,000 shares | +0% | |
| 28Weak | ZOMDFbuy Zomedica Corp. | Russell Kevin Klass Sr Vice President, Sales | $20k 253,007 shares | +5% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.